NCT06469216View on ClinicalTrials.gov

Efficacy of Hyaluronic Acid in Prevention of Acute Radiation Proctitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions
Acute Radiation ProctitisAcute Radiation Enteritis
Interventions
DRUG

Hyaluronic Acid

Hyaluronic Acid to be used as sodium hyaluronate powder plus inactive ingredient (Carboxy methyl cellulose) and to be dissolved in distilled water

OTHER

Placebo

Inactive ingredient (Carboxy methyl cellulose) to be used as powder and to be dissolved in distilled water

Trial Locations (2)

055

Ahmed Maher teaching hospitals, Cairo

Al-Ahrar teaching hospital, Zagazig

All Listed Sponsors
lead

Assiut University

OTHER

NCT06469216 - Efficacy of Hyaluronic Acid in Prevention of Acute Radiation Proctitis | Biotech Hunter | Biotech Hunter